Covered recipient · General Payments record
OLUKAYODE AKINKUNLE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2023
$343.70
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $343.70 | 16 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Indivior Inc. | $122.55 | 5 |
| ITI, Inc. | $67.45 | 3 |
| Alkermes, Inc. | $53.89 | 3 |
| Axsome Therapeutics, Inc. | $53.10 | 2 |
| Janssen Pharmaceuticals, Inc | $16.98 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $16.89 | 1 |
| ABBVIE INC. | $12.84 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2023 | $343.70 | 16 |
Payment records · PY2023 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $12.84 | 08/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999959583 | CMS |
| Alkermes, Inc. | $12.78 | 06/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022767869 | CMS |
| Alkermes, Inc. | $20.09 | 06/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022767871 | CMS |
| Alkermes, Inc. | $21.02 | 07/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022767873 | CMS |
| Axsome Therapeutics, Inc. | $21.09 | 04/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056381451 | CMS |
| Axsome Therapeutics, Inc. | $32.01 | 09/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056381453 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $16.89 | 05/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034303089 | CMS |
| Indivior Inc. | $19.47 | 05/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034281949 | CMS |
| Indivior Inc. | $28.81 | 06/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034281957 | CMS |
| Indivior Inc. | $24.40 | 06/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034281965 | CMS |
| Indivior Inc. | $28.82 | 07/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034281973 | CMS |
| Indivior Inc. | $21.05 | 08/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034281981 | CMS |
| ITI, Inc. | $21.97 | 04/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040761247 | CMS |
| ITI, Inc. | $22.20 | 05/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040761255 | CMS |
| ITI, Inc. | $23.28 | 07/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040761263 | CMS |
| Janssen Pharmaceuticals, Inc | $16.98 | 08/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987768871 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023
- Source files
- Dataset page · Bulk file · PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.